Invention Grant
- Patent Title: GLP-1R modulating compounds
-
Application No.: US17077729Application Date: 2020-10-22
-
Publication No.: US11702404B2Publication Date: 2023-07-18
- Inventor: Stephen E. Ammann , Gediminas J. Brizgys , James S. Cassidy , Elbert Chin , Chienhung Chou , Jeromy J. Cottell , Michael Graupe , Chao-I Hung , Kavoos Kolahdouzan , Scott D. Schroeder , Nathan D. Shapiro , Daniel G. Shore , Suzanne M. Szewczyk , James G. Taylor , Rhiannon Thomas-Tran , Nathan E. Wright , Zheng-Yu Yang , Sheila M. Zipfel
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Main IPC: C07D401/10
- IPC: C07D401/10 ; C07D401/14 ; C07D405/14 ; C07D409/14 ; C07D413/14 ; C07D417/14 ; C07D471/04 ; A61K45/06 ; C07D235/16 ; C07D403/06 ; C07D493/08
Abstract:
The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.
Public/Granted literature
- US20210171499A1 GLP-1R MODULATING COMPOUNDS Public/Granted day:2021-06-10
Information query
